LEP and fatty liver disease: As this inhibition of triglyceride transport is rescued in leptin-deficient mice, regulating VLDL metabolism by hepatic VLDLR, LPL, and leptin may represent a new therapeutic strategy for preventing diet-induced liver steatosis.